Zevra Therapeutics, Inc.
ZVRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54 | $48 | $37 | $34 |
| Short-Term Investments | $145 | $155 | $25 | $36 |
| Receivables | $17 | $18 | $13 | $11 |
| Inventory | $1 | $1 | $3 | $2 |
| Other Curr. Assets | $7 | $4 | $4 | $3 |
| Total Curr. Assets | $225 | $226 | $82 | $86 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $1 |
| Goodwill | $5 | $5 | $5 | $5 |
| Intangibles | $7 | $7 | $67 | $69 |
| Long-Term Investments | $31 | $15 | $6 | $6 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $11 | $11 |
| Total NC Assets | $45 | $30 | $91 | $92 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $270 | $256 | $173 | $178 |
| Liabilities | – | – | – | – |
| Payables | $11 | $0 | $0 | $13 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15 | $28 | $26 | $8 |
| Total Curr. Liab. | $26 | $29 | $27 | $34 |
| LT Debt | $61 | $61 | $60 | $60 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $49 | $48 | $43 | $45 |
| Total NC Liab. | $111 | $110 | $105 | $104 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $2 | $2 | $1 |
| Total Liabilities | $137 | $139 | $132 | $138 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$434 | -$434 | -$508 | -$505 |
| AOCI | -$2 | -$2 | -$0 | $1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $133 | $117 | $41 | $40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $270 | $256 | $173 | $178 |
| Net Debt | $7 | $13 | $23 | $26 |